Correction du gène de la dystrophine avec les nucléases à doigts de zinc

Authors: Iyombe, Jean-Paul
Advisor: Tremblay, Jacques-P.
Abstract: Gene therapy without gene transfer using specific restriction endonucleases is a therapeutic approaches aimed at the development of a cure for Duchenne muscular dystrophy (DMD). To correct the dystrophin gene with zinc finger nucleases (ZFNs) targeting exon 50of DYS gene, we produced ZFNs proteins in bacteria and purified them. The results obtained after in vitro assays show that ZFNs produced specifically recognize a target sequence located in exon 50 of the gene DYS and can be generated in a precise manner the double strand breaks. They also show that ZFNs produced proteins can be transduced with or without agent transduction, in cultured myoblasts of patients’ Duchenne dystrophy.
Document Type: Mémoire de maîtrise
Issue Date: 2013
Open Access Date: 19 April 2018
Grantor: Université Laval
Collection:Thèses et mémoires

Files in this item:
Description SizeFormat 
30298.pdfTexte2.79 MBAdobe PDFThumbnail
All documents in CorpusUL are protected by Copyright Act of Canada.